Randomized Trial of Continuous Versus Intermittent Cefotaxime Infusion on ICU.
NCT02560207
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Critically Ill
Interventions
DRUG:
Cefotaxime
Sponsor
University Medical Center Groningen